Medical Developments International has released a press release.
Licensing deal for Penthrox in Australia
Filed with ASX ·
Watch Medical Developments International's latest callMedical Developments International (ASX:MVP) Q4 2026 Earnings Call · Replay · Aug 19Read the transcript of Medical Developments International (ASX:MVP) Q4 2026 Earnings Call6ix hasn’t read this filing yet.
Medical Developments International Limited on 6ix
Earlier from Medical Developments International
- FY19 Half Year Report and Accounts
- Trading and market update
- Penthrox approved in Hong Kong
- Penthrox is approved in Saudi Arabia
- MVP signs exclusive Penthrox deal for China
Later from Medical Developments International
- Penthrox USA Update
- Positive study results for Penthrox
- Penthrox is launched in Italy
- Penthrox approved in EUSEM guidelines
- MVP signs new Manufacturing Development Project with CSIRO
Follow Medical Developments International into a list and get an email when it puts out news.
Follow Medical Developments International